EPIX Pharmaceuticals has initiated a Phase IIb right-heart catheter study of PRX-08066 in patients with chronic obstructive pulmonary disease (COPD) and moderate-to-severe pulmonary hypertension (PH).
Filed under: Uncategorized | Tagged: 5-HT2b, 5HT2b, Epix, PRX-08066, PRX08066 | Leave a Comment »
